AMERICAN SHARED HOSPITAL SERVICES Line of Credit, Current
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Line of Credit, Current of $2.00 million as of 2025-09-30, per its 10-Q/A filed 2026-01-16.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2026-01-16
- 2025-09-30: Line of Credit, Current $2.00M.
- 2025-06-30: Line of Credit, Current $5.00M.
- 2025-03-31: Line of Credit, Current $2.00M.
- 2024-12-31: Line of Credit, Current $0.00.
| Period end | Line of Credit, Current |
|---|---|
| 2025-09-30 | $2.00M 10-Q/A · filed 2026-01-16 |
| 2025-06-30 | $5.00M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.00M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-Q/A · filed 2026-01-16 |
| 2024-09-30 | $4.50M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.95M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.40M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.50M 10-K · filed 2025-04-04 |
| 2023-09-30 | $1.40M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-19 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 |
| 2014-12-31 | $8.78M 10-K · filed 2016-03-30 |
| 2014-09-30 | $8.28M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $7.71M 10-Q · filed 2014-08-15 |
| 2013-12-31 | $0.00 10-K · filed 2015-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |